Director/PDMR Shareholding
Clinigen Group
925.00p
16:39 04/04/22
![](https://tracker.live.rns-distribution.com/track.live-rns/5186509_af71c28988b39ce6d09c672a2f304d88.png)
16 May 2024
VIDENDUM PLC
Notification of Transactions of Directors and Persons Discharging Managerial Responsibility (PDMRs)
Deferred Bonus Plan - Vesting of 2021 Awards
Videndum plc ("the Company") announces that the following transactions were undertaken by Directors and PDMRs in the ordinary shares of the Company on 15 May 2024 in connection with the maturity of the 2021 Deferred Bonus Plan ("DBP"). In summary, for the 2021 DBP, each Director or PDMR deferred a proportion of their 2020 annual cash bonus into the DBP. The deferred bonus was used to purchase shares in the Company at a price of £13.94 per share ("DBP award shares") that were held in the Employee Trust for a three-year deferral period. No performance conditions are attached to the DBP award shares and dividends paid during the deferral period on the DBP award shares have been automatically reinvested in additional dividend shares. There are no matching award shares that can be earned on the DBP award shares.
Stephen Bird, Group Chief Executive
Transaction | Date of transfer | Total shares vested including dividend shares | Number of shares retained
| Price per share at which associated dividend shares were acquired | Current shareholding following 2021 DBP vesting* (Number in brackets denotes DBP shares still held in trust)
| % of 2024 salary held for Executive Directors** |
Transfer of DBP award shares (including associated dividend shares) | 15 May 2024 | 3,257 (of which 2,537 were DBP award shares) | 3,257 | £2.80 | 329,829 (20,208) | 180% |
Marco Pezzana, PDMR
Transaction | Date of transfer | Total shares vested including dividend shares | Number of shares retained
| Price per share at which associated dividend shares were acquired | Current shareholding following 2021 DBP vesting* (Number in brackets denotes DBP shares still held in trust)
|
Transfer of DBP award shares (including associated dividend shares) | 15 May 2024 | 1,328 (of which 1,034 were DBP award shares) | 1,328 | £2.80 | 151,909 (8,043) |
Jon Bolton, PDMR
Transaction | Date of transfer | Total shares vested including dividend shares | Number of shares retained
| Price per share at which associated dividend shares were acquired | Current shareholding following 2021 DBP vesting* (Number in brackets denotes DBP shares still held in trust)
|
Transfer of DBP award shares (including associated dividend shares) | 15 May 2024 | 425 (of which 331 were DBP award shares) | 425 | £2.80 | 51,822 (2,887) |
* Stephen Bird's current shareholding also reflects 2,000 shares held through a connected person.
** Based on closing mid-market share price on 13 May 2024.
As a consequence of the above transactions, each Executive Director and PDMR has increased their shareholding in the Company.
Enquiries:
Jon Bolton
Group Company Secretary
020 8332 4600
A snapshot of Videndum plc
Videndum is a leading global provider of premium branded hardware products and software solutions to the content creation market. We are organised in three Divisions: Videndum Media Solutions, Videndum Production Solutions and Videndum Creative Solutions.
Videndum's customers include broadcasters, film studios, production and rental companies, photographers, independent content creators ("ICC"), professional musicians and enterprises. Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, smartphone accessories, robotic camera systems, prompters, LED lighting, mobile power, carrying solutions, backgrounds, audio capture, and noise reduction equipment.
We employ around 1,600 people across the world in ten different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.
More information can be found at: https://videndum.com/
LEI number: 2138007H5DQ4X8YOCF14
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.